The down-regulation of IL-6-stimulated fibrinogen steady state mRNA and protein levels by human recombinant IL-1 is not PGE2-dependent: effects of IL-1 receptor antagonist (IL-1RA)
- PMID: 7770069
- DOI: 10.1007/BF00928938
The down-regulation of IL-6-stimulated fibrinogen steady state mRNA and protein levels by human recombinant IL-1 is not PGE2-dependent: effects of IL-1 receptor antagonist (IL-1RA)
Abstract
Infections, trauma and inflammatory processes induce a host response with increases in a large group of structurally and functionally diverse plasma proteins. Parental administration of foreign proteins also induce an increase in plasma fibrinogen. Interleukin-6 (IL-6) is a monocyte-derived mediator and has regulatory effects on acute phase protein genes which result in the induction of fibrinogen synthesis in primary hepatocytes, while the addition of interleukin-1 (IL-1) exerts a negative modulating influence on the IL-6-stimulated fibrinogen. In order to understand the mechanisms by which IL-1 inhibits IL-6-stimulated fibrinogen transcription and translation, and since IL-1 is believed to act through PGE2 stimulation, we have studied the influence of PGE2 in IL-6 or IL-1, alone and in combination, on Fg mRNA expression (by Northern blot analysis) and the influence of PGE2, indomethacin, and arachidonic acid on Fg secretion. Moreover, since human recombinant interleukin-1 receptor antagonist (hrIL-1ra) is a strong inhibitor of IL-1 induced IL-1 transcription and translation and has an inhibitory effect on PGE2, we have studied the effects of IL-1ra on the down-regulation of IL-6 stimulated fibrinogen by IL-1, using an Fg ELISA method.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Synergistic activation of serum amyloid A (SAA) by IL-6 and IL-1 in combination on human Hep 3B hepatoma cell line. Role of PGE2 and IL-1 receptor antagonist.Immunol Invest. 1995 Mar;24(3):523-35. doi: 10.3109/08820139509066848. Immunol Invest. 1995. PMID: 7790046
-
Increased fibrinogen synthesis in mice during the acute phase response: co-operative interaction of interleukin 1, interleukin 6, and interleukin 1 receptor antagonist.Cytokine. 1993 Sep;5(5):454-8. doi: 10.1016/1043-4666(93)90035-4. Cytokine. 1993. PMID: 8142600
-
Inhibition of granuloma formation induced by potassium permanganate in the mouse by a specific human recombinant receptor antagonist for interleukin-1 (hrIL-1ra).Cell Immunol. 1993 Apr 1;147(2):446-57. doi: 10.1006/cimm.1993.1083. Cell Immunol. 1993. PMID: 8384086
-
Blocking the interleukin-1 receptor inhibits leukotriene B4 and prostaglandin E2 generation in human monocyte cultures.Cell Immunol. 1992 Nov;145(1):199-209. doi: 10.1016/0008-8749(92)90323-h. Cell Immunol. 1992. PMID: 1330330
-
Synergism of interleukin 1 and interleukin 6 induces serum amyloid A production while depressing fibrinogen: a quantitative analysis.J Rheumatol. 1994 Mar;21(3):400-5. J Rheumatol. 1994. PMID: 8006883
Cited by
-
Infra-red laser irradiation enhances interleukin-1 receptor antagonist, increases 3H-thymidine incorporation and the release of [3H]arachidonic acid in human monocytes.Mol Cell Biochem. 1997 Apr;169(1-2):51-9. doi: 10.1023/a:1006894711709. Mol Cell Biochem. 1997. PMID: 9089631
-
Regulation of fibrinogen synthesis.Thromb Res. 2024 Oct;242:109134. doi: 10.1016/j.thromres.2024.109134. Epub 2024 Aug 28. Thromb Res. 2024. PMID: 39216273 Review.
-
Levels of interleukin-1 beta can predict response to tocilizumab therapy in rheumatoid arthritis: the PETITE (predictors of effectiveness of tocilizumab therapy) study.Rheumatol Int. 2016 Mar;36(3):349-57. doi: 10.1007/s00296-015-3379-x. Epub 2015 Oct 5. Rheumatol Int. 2016. PMID: 26438386
-
Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism.Biochem J. 2000 Dec 15;352 Pt 3(Pt 3):913-9. Biochem J. 2000. PMID: 11104703 Free PMC article.